| Literature DB >> 34521960 |
Lars Bonitz1,2, Vivienne Wruck2, Elena Peretti2, Dietmar Abel1,2, Stefan Hassfeld1,2, Ákos Bicsák3,4.
Abstract
An update on the trends in maxillofacial traumatology provides additional information on the actual and changing needs. This retrospective study aimed to review all patient records of patients treated for isolated midface fractures in the Department of Cranial- and Maxillofacial Surgery at the Dortmund General Hospital between 2007 and 2017. The patient radiographs and patient files were reviewed. The safety and efficacy of the applied methods were controlled by assessing complications based on the Clavien-Dindo classification system. The statistical analysis included descriptive methods including regression analysis and χ2-test. In eleven years, 3474 isolated midface fracture sites have been identified in 2868 patients. The yearly trend is slightly increasing, in elderly clearly worsening, in children and youth decreasing. The male-to-female ratio was 2.16:1 for the whole study population, in the age group 18-25 y.o. 6.95:1 while in elderly above 80 y.o. 1:2.51, the age group specific incidence reflects this result, too. The most common fractures were nasal bone fractures (1405), zygomatic fractures (832) and orbital floor fractures (700). The average hospital stay was 2.7 days, the most fractures were operated within 24 h. The complication rate was 2.02% (Clavien-Dindo class II-V). The incidence of midfacial fractures is increasing in the total population and especially in elderly, but decreasing in children. Development of injury prevention measures is needed in this population. The diagnostic and therapeutic procedures are appropriate, as there is a low complication rate and short inpatient stay observed.Entities:
Mesh:
Year: 2021 PMID: 34521960 PMCID: PMC8440643 DOI: 10.1038/s41598-021-97858-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Treatment protocol and workflow used at the Department of Oral- and Maxillofacial Surgery at Dortmund General Hospital.
Demographic data.
| Age | Number of patients | Male-to-female ratio | Yearly average incidence | City population (average) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Male | Female | Total | % Total (%) | Male | Female | Total | Male | Female | Total | |||
| 0–3 | 4 | 3 | 7 | 0.2 | 1.33:1 | 0.593 | 4.3 | 3.3 | 3.8 | 8482 | 8253 | 16,735 |
| 3–6 | 11 | 3 | 14 | 0.5 | 3.66:1 | 12.7 | 3.6 | 8.2 | 7894 | 7636 | 15,530 | |
| 6–18 | 226 | 84 | 310 | 10.8 | 2.69:1 | < | 61.9 | 24.7 | 44.0 | 33,211 | 30,911 | 64,122 |
| 18–25 | 459 | 66 | 525 | 18.3 | 6.95:1 | < | 149.9 | 23.8 | 90.0 | 27,846 | 25,169 | 53,015 |
| 25–35 | 373 | 74 | 447 | 15.6 | 5.04:1 | < | 74.7 | 16.3 | 46.9 | 45,418 | 41,314 | 86,732 |
| 35–50 | 387 | 122 | 509 | 17.7 | 3.17:1 | < | 57.2 | 19.1 | 38.7 | 61,486 | 58,191 | 119,677 |
| 50–65 | 263 | 126 | 389 | 13.6 | 2.08:1 | < | 38.3 | 18.2 | 28.2 | 62,484 | 62,784 | 125,268 |
| 65–80 | 145 | 195 | 340 | 11.9 | 1:1.34 | < | 34.2 | 38.2 | 36.4 | 38,539 | 46,467 | 85,006 |
| 80+ | 93 | 234 | 327 | 11.4 | 1:2.51 | < | 67.9 | 94.1 | 84.8 | 12,456 | 22,609 | 35,065 |
| Total | 1961 | 907 | 2868 | 100 | 2.16:1 | < | 146.3 | 66.5 | 106.0 | 297,816 | 303,334 | 601,150 |
The p value refers to the gender difference (χ2-test, confidence interval 95%, significant values in Italics). In the study time frame, the city population was relatively stable with a yearly change of ± 1.000, thus the report from 2017 was taken as the basis.
Figure 2Yearly variance of the number of patients admitted to hospital with midface fracture.
Figure 3Yearly average incidence of midface fractures in different age groups. (The incidence is given N/100,0000/year, the reference is the city population given in Table 1).
List of the fracture sites.
| Left | Right | Total | % of midface fractures (%) | ||
|---|---|---|---|---|---|
| Nasal bone | x | x | 1405 | 40.4 | |
| Zygomatic bone | 471 | 361 | 832 | 23.9 | < 0.001 |
| Orbital floor | 394 | 306 | 700 | 20.1 | < 0.001 |
| Zygomatic arch, isolated | 85 | 67 | 152 | 4.4 | 0.038 |
| Le fort I | 60 | 56 | 116 | 3.3 | 0.599 |
| Le fort II | 34 | 31 | 65 | 1.9 | 0.599 |
| Dentoalveolar | x | x | 61 | 1.8 | |
| Maxillary sinus wall | 14 | 26 | 40 | 1.2 | 0.007 |
| Orbital roof | 14 | 21 | 35 | 1.0 | 0.094 |
| Naso-orbito-ethmoid, Type II | 9 | 11 | 20 | 0.6 | 0.527 |
| Naso-orbito-ethmoid, Type I | 8 | 6 | 14 | 0.4 | 0.449 |
| Orbito-ethmoid | 6 | 6 | 12 | 0.3 | 1 |
| Le fort III | 3 | 4 | 7 | 0.2 | 0.593 |
| Naso-orbito-ethmoid, Type III | 4 | 3 | 7 | 0.2 | 0.593 |
| Other upper jaw | 4 | 1 | 5 | 0.1 | 0.058 |
| Hard palate | 2 | 1 | 3 | 0.1 | 0.414 |
| Total | 3474 |
The p value refers to the difference between the left and right-sided fractures (χ2-test, confidence interval 95%). In the column [%] of midface fractures the proportion of fractures in a region in relation to all midface fractures are shown in percents.
Figure 4The average duration from admission to surgery and from surgery to discharge (in days), for primary and secondary surgeries (values rounded).
Osteosynthesis implant usage (Medartis Modus Midface®).
| Plate | Holes | Full length | Shortended | Total | % of total implants (%) |
|---|---|---|---|---|---|
| 2.0 mm straight, without bar | 4 | 500 | 0 | 500 | 37.6 |
| 1.5 mm without bar | 4 | 130 | 1 | 131 | 9.9 |
| 1.5 mm without bar | 8 | 84 | 36 | 120 | 9.0 |
| 1.5 mm without bar | 6 | 99 | 15 | 114 | 8.6 |
| L/Y/T-shaped 1.5 mm | Any | 102 | 10 | 112 | 8.4 |
| 2.0 mm with bar | 4 | 72 | 0 | 72 | 5.4 |
| 2.0 mm without bar | 4 | 52 | 0 | 52 | 3.9 |
| Orbital mesh, 0.1 mm | – | 0 | 46 | 46 | 3.5 |
| Other | – | – | – | 182 | 13.7 |
| Total | – | – | – | 1329 | 100 |
List of the complications in different regions and their proportion to all midface complications.
| Complication | Complication site | Total | % of total (%) |
|---|---|---|---|
| Excessive scarring | Zygomatic bone | 12 | 20.7 |
| Naso-orbito-ethmoid | |||
| Wound healing problem | Zygomatic bone | 8 | 13.8 |
| Le fort I | |||
| Insufficient reposition | Zygomatic bone | 8 | 13.8 |
| Le fort I | |||
| Infection | Le fort I | 5 | 8.6 |
| Zygomatic bone | |||
| Screw loosening | Zygomatic bone | 4 | 6.9 |
| Le fort II | |||
| Osteointegration | Zygomatic bone | 3 | 5.2 |
| Hypesthesia | Zygomatic bone | 3 | 5.2 |
| Postoperative retrobulbar hematoma | Orbital floor | 1 | 1.7 |
| Pansinusitis | Zygomatic bone | 1 | 1.7 |